NCK2025 offers protection against induced colitis in pre-clinical study
Posted by Khashayarsha Khazaie, Mojgan Zadeh, Mohammad W Khan, Praveen Bere, Fotini Gounari, Kirsten Dennis, Nichole R Blatner, Jennifer L Owen, Todd R Klaenhammer, and Mansour Mohamadzadeh on Sep 16th 2025
This pre-clinical study highlights the long-term benefits of CodonRX in colon health. In this study, CodonRX showed a remarkable ability to support a healthy colon lining and protect against colonic polyps.
The active ingredient behind CodonRX is NCK2025.
Read more here.